Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Remdesivir, tocilizumab and CPT included in revised protocols for COVID-19 clinical management

expresspharmaJune 15, 2020

Tag: Remdesivir , Tocilizumab , CPT , COVID-19 , ICMR

PharmaSources Customer Service